Melatonin Tablet Manufacturing and Formulation

The contract encompasses the full-scale manufacture of melatonin tablets adhering to the detailed specifications outlined under NSN Part 6505017028490, covering all stages from active pharmaceutical ingredient sourcing to final batch release. Production activities include formulation, compression into tablets, and rigorous quality control procedures to ensure compliance with established standards, with all work performed under a subcontract arrangement. The contracting entity is the Defense Logistics Agency, operating under the Department of Defense, and the work is classified under NAICS code 325412 for pharmaceutical and medicine manufacturing. The contract was posted on August 5, 2026, with performance obligations tied to the referenced procurement and delivery identifiers, though specific geographic performance locations are not detailed. All deliverables must meet the technical and regulatory requirements of the specified NSN, and the contract remains subject to the oversight and compliance protocols of the U.S. Department of Defense supply chain.